I didn't say it wouldn't be worth it, just that it's expensive. There are certainly access issues to consider here if this comes to market.

Some people don't have $4000 so it's not a matter of deciding whether parting with that much money is worthwhile.

And the status of a lot of people's health insurance is suddenly up in the air.

First result on Googling the normal cost of cancer treatments

> Newly approved cancer drugs cost an average of $10,000 per month, with some therapies topping $30,000 per month, according to ASCO, which discussed the costs of cancer care at a recent meeting. Just a decade ago, the average cost per month of new drugs was about $4,500.

It seems $4,000 is rather a small fee in comparison.

Nitpick: it's $4000 per dose, and you're comparing to the monthly cost

> Some people don't have $4000 so it's not a matter of deciding whether parting with that much money is worthwhile.

But then those people wouldn't be able to afford other treatments either.

The insurance market and the government providing medicaid loves these types of cures. An effective cure that costs a few thousand dollars is obviously worth the healthy cured people living to pay premiums for the rest of their healthy life. Much preferable to a costly patient needing many treatments in the tens of thousands of dollars in the insurance pool. The economics are much better than what the system currently bears.